Jakeccc

CELG wants to Part-ay

NASDAQ:CELG   CELGENE CORP
55 2 0
CELG             went into WITSEC last week due to the uncertainty surrounding its patent fight with Natco, the Markman hearing report came out today, I don't know much, well, anything about patent law, but ISI analyst Mark Schoenebaum, a very prudent and credible analyst in my opinion (helped me make a sht load of $ off GILD) said the result looked "OK", which is good enough for me.

I'll probably disappoint you guys because I don't know much about figuring out entry point and I don't pretend to know. What I do know is don't be afraid to buy high and sell higher. So long term investor shouldn't miss this opportunity just because they want to wait for another pull back. For traders, you might've missed the first half of the recovery, but there's still some room to run, and I don't see anything keeping it down in the forseeable future. CELG             has a PEG ratio less than 1, and a very diversified drug pipeline (just check its pipeline on Celgene             website).

A caveat, Gilead, the bastard that dragged the whole bitoech sector to the mud 2 months ago, was in the red last Friday, partially due to Sovaldi prescription, but it was also because its pricing practice was under scrutiny again. This is all too familiar which is why I'm neutral (I bot some shares at 145 and bot some July DTM calls 130 at 20 last week, sold all my shares today but kept my calls), or maybe I'm just being paranoid, but again, you can never be too careful in this market.
I4
2 years ago
I do like your postings on more potential in the Biotech sector but I believe their uptrend will soon come to an end. If you check out AMGN, CELG, GILD on a LOG chart "which is preferred since they have gone up hundreds of percent", they have all broken trendlines that haven't been broken from a starting point of mid 2011 to mid 2012. These three big names could be an early signal for other Bio-techs to follow, such as REGN which is also on the brim of breaking a longterm trendline on a weekly log chart as well. Since there was a intermediate sell-off in a majority of Biotechs throughout march and april, Biotechs may be pullback phase before a further downtrend occurs. GILD is my favorite example of a potential pullback, forming a double top formation. However, I may be wrong so I must always try to take other peoples point of view,but you got to ask yourself how much more can Bio-tech stocks can go? BIIB over 700%since mid 2010, GILD 460% since 2012, REGN 2400% since 2009.
Reply
Jakeccc I4
2 years ago
You're right, I actually sold all my GILD at 83.5 a couple days ago, and sold BIIB yesterday (didn't think there'd be an upgrade right after I sold, what are the odds...) at 309 and trimmed my REGN. Position by 50%. The reason why I kept some REGN is that Sanofi bot so many of its stocks and promised not to sell till 2020, so that's like a temporary 20% stock buy back, the float now is very low, but again the demand seems low to me too :( and I'll admit the chart looks ugly and the PE is insane. The way that GILD got rejected at 84 was scary, and very worrisome to me. I think the whole market might pull back before it goes higher, not just biotech. If you think of this year, the pattern is very clear, first the emerging market currency crisis at the beginning of the year, it sold off, and then right after that, Ukraine, sold off again and now what? I think the Chinese and its southeastern Asian neighbors territory disputes will erupt very soon and scare the market shtless again. It's already been brewing since last week, but people don't notice it because they're too busy celebrating Putin pulling back his troops and S&P making new highs.
Reply
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out